
WHO Sets Strict Limits on GLP-1 Drugs for Children Under 10
The World Health Organization released its first global guidelines for managing childhood obesity, explicitly advising against the use of GLP-1 weight-loss medications, bariatric surgery, or weight-management devices for children under 10. For adolescents aged 10 to 19, medical interventions are permitted only after supervised lifestyle programs fail. The guidelines emphasize healthy eating, physical activity, and digital tools as primary strategies, citing a quadrupling of obesity rates in this age group since 1990.












